GTGuowei Tan

Guowei Tan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Guowei Tan has a total of 88 co-authors. Here are the top co-authors by number of shared publications:

  • Xi Chen

    3 shared publications
  • Chengkun Han

    Department of Nuclear Medicine and Minnan PET Center, Xiamen Key Laboratory of Radiopharmaceuticals, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

    2 shared publications
  • Jianyao Mao

    2 shared publications
  • Sifang Chen

    Department of Neurosurgery the First Affiliated Hospital of Xiamen University Xiamen China

    2 shared publications
  • Weichao Jiang

    Department of Neurosurgery the First Affiliated Hospital of Xiamen University Xiamen China

    2 shared publications
  • Yukui Li

    Department of Neurosurgery, First Affiliated Hospital of Xiamen University, Xiamen, China

    2 shared publications

Latest Publications

  • Systolic blood pressure modifies the association between triglyceride-glucose-waist-to-height ratio and cardiovascular disease: a nationwide cohort study

    by Junfu Chen, Ping Zhong, Zhangyu Li, Jianyao Mao, Xi Chen, Wentao Zheng, Sifang Chen, Guowei Tan, Zhanxiang Wang, Qinghai Huang

  • Open Access

    Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma

    by Yaning Qin, Zhiqi Liang, Mengqin Yu, Nanqian Lin, Naizhen Wang, Xuanke Huang, Shi Chen, Qun Peng, Yanhua Lin, Heqin Wang, et al.

    Glioblastoma (GBM) is an incurable brain tumor characterized by high heterogeneity. Oncolytic viruses (OVs) are an approved therapy, but their efficacy is often limited by poor cellular permissiveness to infection. Here we screen bioactive compounds to identify enhancers of oncolytic herpes simplex virus (oHSV) in GBM and discover a brain-penetrant leucine-rich repeat kinase 2 (LRRK2) inhibitor as the strongest sensitizer. Pharmacological LRRK2 inhibition potentiates oHSV infection and oncolysis across diverse GBM cell lines and improves therapeutic outcomes in patient-derived xenograft and orthotopic models. Mechanistically, LRRK2 interacts with and promotes STAT1 phosphorylation at Y701, which drives interferon-independent antiviral responses. Consequently, LRRK2 inhibition attenuates these host defenses, thereby enhancing tumor-selective viral replication. Elevated LRRK2 levels in GBM correlate with reduced oHSV sensitivity, suggesting LRRK2 as a predictive biomarker for tumors amenable to oHSV therapy. Our findings support the combination of LRRK2 inhibitors with oHSV as a promising therapeutic strategy for aggressive GBM.


  • Open Access

    Electrophysiological monitoring of trigeminal nerve sensory root using sensory-masseter response for microvascular decompression in trigeminal neuralgia

    by Weichao Jiang, Yin Kang, Huijuan Wan, Lihui Lin, Siqi Wu, Hongwei Zhu, Xiaohua Lin, Jiayang Liu, Guowei Tan, Zhanxiang Wang, et al.

    Purpose Trigeminal neuralgia (TN), a debilitating condition, is commonly treated with microvascular decompression (MVD). However, effective intraoperative neurophysiological monitoring remains challenging. This study introduces a novel electrophysiological technique using sensory-masseter response (SMR) to monitor trigeminal nerve compression during MVD. Methods A total of 34 patients with TN underwent MVD. A concentric neurostimulator was employed to systematically deliver microcurrent stimulation to various intracranial segments of the trigeminal sensory root. We specifically probed the segment distal to the suspected neurovascular conflict (NVC) site, the actual compression point itself, and the segment central to the NVC site. Stimulation was performed at equivalent anatomical levels on both the compressed and non-compressed sides for comparison. Simultaneously, compound muscle action potentials (CMAPs) were recorded from the masseter muscle. These recorded potentials were defined as the SMR. The spatial correlation between SMR positivity and NVC was analyzed to assess its clinical utility. Results SMR was successfully recorded in 28 out of 34 patients (82.4%). Among these 28 SMR-positive cases, NVC was identified at the stimulation site in 24 cases, with 19 showing visible vascular indentation. The mean SMR latency was 3.30 ± 0.36 ms. The stimulation threshold required to elicit SMR was significantly lower at the NVC site (median 0.3 mA, IQR 0.2–0.4 mA) compared to the distal segment of the NVC side (p < 0.001), the non-compressed side (p < 0.001), and the central segment of the NVC side (p = 0.012). A strong association was observed between NVC and SMR positivity (p < 0.001). These findings suggest that SMR positivity correlates with NVC sites. Conclusion This study introduces a novel electrophysiological technique SMR for localizing NVC during microvascular decompression for trigeminal neuralgia. SMR is likely mediated by focal demyelination and sensory-motor anastomoses. Although SMR demonstrates potential in assisting intraoperative localization during MVD, its clinical value requires further validation.


  • Open Access

    Epigenetic and transcriptomic analysis revealed ceRNA regulatory network in glioblastoma multiforme

    by Zhenghui Li, Yanqing Li, Jenna Z. Liang, Tianxiang Geng, Jing Chen, Yangyang Yuan, Yufang Sui, Wanhong Zhang, Qian Chen, Guowei Tan, et al.

    Glioblastoma multiforme (GBM) is one of the most common cancers among malignant tumors, and extensive evidence suggests that the prognosis of various human cancers is associated with DNA methylation. Therefore, we analyzed potential GBM prognostic biomarkers by combining GBM methylation sequencing data and transcriptome sequencing data. Biostatistical analysis of the expression of three RNA types (long non-coding RNA, microRNA, and mRNA) from The Cancer Genome Atlas (TCGA) was performed to determine the correlation between NACAD and GBM prognosis. Additionally, we predicted and validated a competitive endogenous RNA (ceRNA) regulatory network associated with epigenetic DNA methylation modifications. The ceRNA regulatory network (DCTN1-AS1–hsa-let-7a-5p–NACAD) was found to be related to overall survival (OS) and disease-specific survival (DSS) of GBM. Furthermore, we identified NACAD as an independent prognostic factor for both GBM OS and DSS. In summary, comprehensive analysis of methylation and transcriptome data led to the identification of genes and pathways in different GBM subtypes, highlighting prognostic genes and ceRNA regulatory networks, and proposing potential candidates.


  • Open Access

    68Ga-FAPI-46 PET/CT in the evaluation of gliomas: comparison with 18F-FDG PET/CT and contrast-enhanced MRI

    by Dan Ruan, Jianping Sun, Chengkun Han, Jiayu Cai, Lingyu Yu, Liang Zhao, Yizhen Pang, Changjing Zuo, Long Sun, Zhanxiang Wang, et al.

    Rationale: This study compared 68Ga-FAPI-46 PET/CT, 18F-fluorodeoxyglucose (FDG) PET/CT, and contrast-enhanced MRI (CE-MRI) for glioma imaging, classification, and recurrence detection and explored PET parameters and molecular pathological profiles.


  • Open Access

    Proteomic and metabolomic analyses illustrate the mechanisms of expression of the O 6 ‐methylguanine‐DNA methyltransferase gene in glioblastoma

    by Xi Chen, Jinli Sun, Yukui Li, Weichao Jiang, Zhangyu Li, Jianyao Mao, Liwei Zhou, Sifang Chen, Guowei Tan

    Aim: Glioblastoma (GBM) has been reported to be the most common high‐grade primary malignant brain tumor in clinical practice and has a poor prognosis. O 6 ‐methylguanine‐DNA methyltransferase (MGMT) promoter methylation has been related to prolonged overall survival (OS) in GBM patients after temozolomide treatment. Methods: Proteomics and metabolomics were combined to explore the dysregulated metabolites and possible protein expression alterations in white matter (control group), MGMT promoter unmethylated GBM (GBM group) or MGMT promoter methylation positive GBM (MGMT group). Results: In total, 2745 upregulated and 969 downregulated proteins were identified in the GBM group compared to the control group, and 131 upregulated and 299 downregulated proteins were identified in the MGMT group compared to the GBM group. Furthermore, 131 upregulated and 299 downregulated metabolites were identified in the GBM group compared to the control group, and 187 upregulated and 147 downregulated metabolites were identified in the MGMT group compared to the GBM group. The results showed that 94 upregulated and 19 downregulated proteins and 20 upregulated and 16 downregulated metabolites in the MGMT group were associated with DNA repair. KEGG pathway enrichment analysis illustrated that the dysregulated proteins and metabolites were involved in multiple metabolic pathways, including the synthesis and degradation of ketone bodies, amino sugar and nucleotide sugar metabolism. Moreover, integrated metabolomics and proteomics analysis was performed, and six key proteins were identified in the MGMT group and GBM group. Three key pathways were recognized as potential biomarkers for recognizing MGMT promoter unmethylated GBM and MGMT promoter methylation positive GBM from GBM patient samples, with areas under the curve of 0.7895, 0.7326 and 0.7026, respectively. Conclusion: This study provides novel mechanisms to understand methylation in GBM and identifies some biomarkers for the prognosis of two different GBM types, MGMT promoter unmethylated or methylated GBM, by using metabolomics and proteomics analyses.


  • Open Access

    Fluorescein-guided surgery for high-grade glioma resection: a five-year-long retrospective study at our institute

    by Chen Xi, Sun Jinli, Mao Jianyao, Chen Yan, Li Huijuan, Shi Zhongjie, Li Zhangyu, Zhou Liwei, Li Yukui, Chen Sifang, et al.

    Objective: This study investigates the extent of resection, duration of surgery, intraoperative blood loss, and postoperative complications in patients with high-grade glioma who received surgery with or without sodium fluorescein guidance.Methods: A single-center retrospective cohort study was conducted on 112 patients who visited our department and underwent surgery between July 2017 and June 2022, with 61 in the fluorescein group and 51 in the non-fluorescein group. Baseline characteristics, intraoperative blood loss, surgery duration, resection extent, and postoperative complications were documented.Results: The duration of surgery was significantly shorter in the fluorescein group than in the non-fluorescein group (P = 0.022), especially in patients with tumors in the occipital lobes (P = 0.013). More critically, the gross total resection (GTR) rate was significantly higher in the fluorescein group than in the non-fluorescein group (45.9% vs. 19.6%, P = 0.003). The postoperative residual tumor volume (PRTV) was also significantly lower in the fluorescein group than in the non-fluorescein group (0.40 [0.12-7.11] cm3 vs. 4.76 [0.44-11.00] cm3, P = 0.020). Particularly in patients with tumors located in the temporal and occipital lobes (temporal, GTR 47.1% vs. 8.3%, P = 0.026; PRTV 0.23 [0.12-8.97] cm3 vs. 8.35 [4.05-20.59] cm3, P = 0.027; occipital, GTR 75.0% vs. 0.0%, P = 0.005; PRTV 0.15 [0.13-1.50] cm3 vs. 6.58 [3.70-18.79] cm3, P = 0.005). However, the two groups had no significant difference in intraoperative blood loss (P = 0.407) or postoperative complications (P = 0.481).Conclusions: Fluorescein-guided resection of high-grade gliomas using a special operating microscope is a feasible, safe, and convenient technique that significantly improves GTR rates and reduces postoperative residual tumor volume when compared to conventional white light surgery without fluorescein guidance. This technique is particularly advantageous for patients with tumors located in non-verbal, sensory, motor, and cognitive areas such as the temporal and occipital lobes, and does not increase the incidence of postoperative complications.


  • Awake craniotomy for removal of gliomas in eloquent areas: An analysis of 21 cases

    by Xi Chen, Jinli Sun, Weichao Jiang, Zhi Zhu, Sifang Chen, Guowei Tan, Zhanxiang Wang


  • Open Access

    Automatic Seizure Classification Based on Domain-Invariant Deep Representation of EEG

    by Xincheng Cao, Bin Yao, Binqiang Chen, Weifang Sun, Guowei Tan

    Accurate identification of the type of seizure is very important for the treatment plan and drug prescription of epileptic patients. Artificial intelligence has shown considerable potential in the fields of automated EEG analysis and seizure classification. However, the highly personalized representation of epileptic seizures in EEG has led to many research results that are not satisfactory in clinical applications. In order to improve the clinical adaptability of the algorithm, this paper proposes an adversarial learning-driven domain-invariant deep feature representation method, which enables the hybrid deep networks (HDN) to reliably identify seizure types. In the train phase, we first use the labeled multi-lead EEG short samples to train squeeze-and-excitation networks (SENet) to extract short-term features, and then use the compressed samples to train the long short-term memory networks (LSTM) to extract long-time features and construct a classifier. In the inference phase, we first adjust the feature mapping of LSTM through the adversarial learning between LSTM and clustering subnet so that the EEG of the target patient and the EEG in the database obey the same distribution in the deep feature space. Finally, we use the adjusted classifier to identify the type of seizure. Experiments were carried out based on the TUH EEG Seizure Corpus and CHB-MIT seizure database. The experimental results show that the proposed domain adaptive deep feature representation improves the classification accuracy of the hybrid deep model in the target set by 5%. It is of great significance for the clinical application of EEG automatic analysis equipment.


  • Open Access

    Evolutionary Multitasking-Based Multiobjective Optimization Algorithm for Channel Selection in Hybrid Brain Computer Interfacing Systems

    by Tianyu Liu, Zhixiong Xu, Lei Cao, Guowei Tan

    Hybrid-modality brain-computer Interfaces (BCIs), which combine motor imagery (MI) bio-signals and steady-state visual evoked potentials (SSVEPs), has attracted wide attention in the research field of neural engineering. The number of channels should be as small as possible for real-life applications. However, most of recent works about channel selection only focus on either the performance of classification task or the effectiveness of device control. Few works conduct channel selection for MI and SSVEP classification tasks simultaneously. In this paper, a multitasking-based multiobjective evolutionary algorithm (EMMOA) was proposed to select appropriate channels for these two classification tasks at the same time. Moreover, a two-stage framework was introduced to balance the number of selected channels and the classification accuracy in the proposed algorithm. The experimental results verified the feasibility of multiobjective optimization methodology for channel selection of hybrid BCI tasks.